bioRxivSystems BiologyPreprint
Cancer-associated fibroblasts drive metabolic heterogeneity in KRAS-mutant colorectal cancer cells
Elizabeth EltoniD, Niki Tavakoli, Handan ÇetiniD, Stacey D. FinleyiD
Abstract
KRAS-mutant colorectal cancer (CRC) is characterized by metabolic reprogramming that can lead to tumor progression and drug resistance. The tumor microenvironment (TME) plays a pivotal role in modulating these metabolic adaptations. In particular, cancer-associated fibroblasts (CAFs), which make up a large portion of the TME, have been shown to strongly contribute to metabolic reprogramming in CRC. This study applies flux sampling, a computational method that explores the full range of feasible metabolic states, combined with representation learning and hierarchical clustering, to a computational model of central carbon metabolism to understand how CAFs influence metabolic adaptations of KRAS-mutant CRC cells following targeted enzyme knockdowns. Focusing on twelve key enzymes involved in glycolysis and the pentose phosphate pathway, knockdowns were simulated under both normal CRC media and CAF-conditioned media (CCM) conditions. Analysis revealed that CCM induces greater metabolic heterogeneity, with knockdown models exhibiting more variable and distinct metabolic states compared to those cultured in normal CRC media. While some enzyme knockdowns produced similar metabolic states, this overlap was less frequent in CCM, indicating that CAF-derived factors diversify the metabolic responses of CRC cells to enzyme perturbations. Pathway-level flux analysis demonstrated media-specific shifts in central carbon metabolism pathways. Importantly, the predicted biomass flux showed that enzyme knockdowns reduced growth across both conditions, but models in the CCM condition indicated CAFs could offer a protective effect against metabolic perturbation. Overall, this study reveals that CCM significantly influences the metabolic state and adaptability of KRAS-mutant CRC cells to enzyme perturbations, emphasizing the importance of including TME components in metabolic modeling and therapeutic development. These findings provide valuable insights into the metabolic adaptability of CRC and suggest that targeting tumor-CAF metabolic interactions may improve treatment strategies. Graphical Abstract Overview of computational workflowModels of interest represent simulated enzyme knockdowns in central carbon metabolism. Flux sampling searches the entire metabolic solution space and results in a distribution of flux values for each reaction within each model. Samples can be organized by knockdown and condition into matrices for input into representation learning. Representation learning is applied to sampling data to identify shared and independent metabolic states. Metabolic states indicate a heterogeneous response to enzyme knockdowns. Overlap of dark and light blue flux distributions, sampling clusters, and metabolic responses exemplify a shared metabolic state separate from to the gray unperturbed state. This workflow provides a low-dimensional representation of metabolic state that captures both the pathway- and reaction-level differences that describe each simulated knockdown. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=172 SRC="FIGDIR/small/679631v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@cb6226org.highwire.dtl.DTLVardef@98d94eorg.highwire.dtl.DTLVardef@e2b20aorg.highwire.dtl.DTLVardef@116cfcd_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Elucidating Tumor-stromal Metabolic Crosstalk in Colorectal Cancer through Integration of Constraint-Based Models and LC-MS Metabolomics
Junmin Wang, Alireza Delfarah, … Stacey D. Finley·Metabolic EngineeringPeer-reviewed·Nov 25, 2021
- Merging metabolic modeling and imaging for screening therapeutic targets in colorectal cancer
Niki Tavakoli, Emma J. Fong, … Shannon M. Mumenthaler·npj Systems Biology and ApplicationsPeer-reviewed·Jan 28, 2025
- Modulation of fibroblasts phenotype by colorectal cancer cells-secreted factors is mostly independent of oncogenic KRAS
P. Dias Carvalho, S. Mendonca, … S. Velho·CellsPeer-reviewed·Aug 11, 2022
- Discovery of decreased ferroptosis in male colorectal cancer patients with KRAS mutations
H. Yan, R. Talty, … C. Johnson·bioRxiv·Feb 28, 2023
- Unveiling the Mechanisms to Bypass KRAS Inhibition: In Vitro Insights into the Influence of Fibroblast-Secretome
Susana Mendonça Oliveira, Patrícia Dias Carvalho, … Sérgia Velho·bioRxiv·Apr 19, 2024
- KRAS G12 mutant alleles differentially control glutamine metabolism via FOXO1
Suzan Ber, Ming Hui Yang, … Alessandro Esposito·EMBO ReportsPeer-reviewed·Nov 20, 2025